Skip to main content
. 2021 Feb 19;25:e00208. doi: 10.1016/j.plabm.2021.e00208

Fig. 2.

Fig. 2

Longitudinal Results of Abbott SARS-Co-V2 IgM and IgG in Molecular Positive Pediatric Patients. Data is shown for IgM results, after NAAT positive result (A) and after symptom onset (C). Data for IgG after NAAT positive result (B) and after symptom onset (D). Five asymptomatic patients were excluded from C and D IgM vertical axis is in log scale. Orange dotted line represents cutoffs, IgM (1.0) and IgG (1.4). Dark horizontal bars represent the median value for that time period. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)